Tech Company Financing Transactions
MIACH Orthopaedics Funding Round
Amzak Health Investors, DSM Venturing and National Football League participated in a $22.5 million Series A venture round for MIACH Orthopaedics. This VC investment round was announced on 9/18/2018.
Transaction Overview
Company Name
Announced On
9/18/2018
Transaction Type
Venture Equity
Amount
$22,500,000
Round
Series A
Investors
Proceeds Purpose
The proceeds will be used for accelerating manufacturing capabilities and to continue U.S. clinical trials of MIACH Orthopaedics' first implant, the Bridge-Enhanced ACL Repair (BEAR), designed to stimulate healing of a torn anterior cruciate ligament (ACL).
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
300 Longwood Ave.
Boston, MA 02115
USA
Boston, MA 02115
USA
Phone
Undisclosed
Email Address
Not Recorded
Overview
MIACH Orthopaedics, Inc. is a privately held company located in Boston, Massachusetts, dedicated to developing bio-engineered surgical implants for connective tissue repair. The company's initial focus is on the Bridge-Enhanced ACL Repair (BEAR) technology as a viable alternative to conventional ACL reconstruction for patients who have sustained an ACL injury.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Founder
Martha Murray
Browse more venture capital transactions:
Prev: 9/18/2018: Emplify venture capital transaction
Next: 9/18/2018: SCYTHE venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. VC investment data records on this site are sourced from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs